The Issue Of Price Inflations Revolving Around The Epipen Essay

1986 Words Dec 1st, 2016 8 Pages
EpiPens are arguably one of the most important devices for those to carry who suffer from life-threatening allergies. Recent issues of price inflations revolving around the EpiPen have been beginning to surface in the media. This certain inflation has made the public more aware of the pharmaceutical world and the loopholes of pricing. The issue of pricing in the pharmaceutical world is nothing new, but is also not very publicly known. Big name companies have been increasing their prices over the years to the point of being almost impossible to afford without the aid of financial assistance programs or insurance. Mylan Pharmaceuticals is one of those big name companies with a near monopoly on their auto-injector device, the EpiPen. Mylan pharmaceuticals has inflated their prices from 2007 by almost 400%. In the article, “Why Did Mylan Hike EpiPen Prices 400%? Because They Could,” by Emily Willingham, Willingham states that “Somewhere, right now, a cash-strapped parent or budget-limited patient with a severe allergy will skip acquiring an EpiPen… someday, they will need it… and they will die. Two turning points, a death and one company at the crossroads” (1). These patients could not afford a device filled with $1 worth of epinephrine to keep them alive. So why is the price inflating in the Mylan’s EpiPen when the drug itself is so cheap? The first argument proposes reasons as to why Mylan Pharmaceuticals current cost of the EpiPen remains as what it is and as to why it came…

Related Documents